gabexate has been researched along with fibrinogen in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, M; Haramoto, T; Kumagai, I; Makino, H; Murakami, K; Ogura, T; Onbe, T; Ota, Z; Wada, J | 1 |
| Imanishi, N; Komuro, Y; Morooka, S | 1 |
| Gando, S; Tedo, I | 1 |
| Matsuda, T | 1 |
| Imaoka, S; Kambayashi, J; Kosaki, G | 1 |
| Furukawa, Y; Kondo, M; Murakami, M; Takemura, S; Yoshikawa, T | 1 |
| Kohno, Y; Koishi, K; Nishiyama, T | 1 |
| Matsumoto, T; Wada, H; Yamashita, Y | 1 |
| Aota, T; Imai, H; Isaji, S; Katayama, N; Matsumoto, T; Ohishi, K; Suzuki, K; Usui, M; Wada, H; Yamashita, Y | 1 |
| Fujita, K; Hosono, N; Ito, K; Iwasaki, H; Kishi, S; Lee, S; Matsuda, Y; Morita, M; Negoro, E; Oiwa, K; Ookura, M; Tai, K; Tasaki, T; Ueda, T; Yamauchi, T | 1 |
2 review(s) available for gabexate and fibrinogen
| Article | Year |
|---|---|
[Therapy of disseminated intravascular coagulation].
Topics: Antifibrinolytic Agents; Antithrombin III; Blood Coagulation Tests; Blood Transfusion; Disseminated Intravascular Coagulation; Factor VIII; Fibrinogen; Gabexate; Guanidines; Heparin; Humans; Platelet Transfusion; Vitamin K | 1985 |
[Recent therapeutic strategy for disseminated intravascular coagulation].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coagulation; Fibrinogen; Gabexate; Guanidines; Heparin; Humans; Molecular Targeted Therapy; Plasma; Platelet Transfusion; Practice Guidelines as Topic; Serine Proteinase Inhibitors; Thrombomodulin | 2014 |
1 trial(s) available for gabexate and fibrinogen
| Article | Year |
|---|---|
Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Antithrombins; C-Reactive Protein; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Humans; Intensive Care Units; Leukocyte Count; Male; Middle Aged; Partial Thromboplastin Time; Peptide Hydrolases; Platelet Count; Prothrombin Time; Single-Blind Method | 2012 |
7 other study(ies) available for gabexate and fibrinogen
| Article | Year |
|---|---|
[Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Complement System Proteins; Creatinine; Drug Evaluation; Esters; Female; Fibrinogen; Gabexate; Glomerulonephritis; Granulocytes; Guanidines; Hematuria; Humans; Male; Middle Aged; Pancreatic Elastase; Protease Inhibitors; Proteinuria | 1991 |
Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).
Topics: Administration, Oral; Animals; Disseminated Intravascular Coagulation; Endotoxins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Infusions, Intravenous; Injections, Intraperitoneal; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Count; Prothrombin Time; Rats; Thiazoles; Thiazolidines | 1991 |
[An analysis of disseminated intravascular coagulation by fibrinopeptides].
Topics: Adult; Aged; Blood Coagulation; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Fibrinopeptide B; Gabexate; Guanidines; Humans; Male; Middle Aged; Peptide Fragments | 1988 |
Application of a synthetic serine protease inhibitor in the treatment of DIC.
Topics: Animals; Chemical Phenomena; Chemistry; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Fibrinolysis; Gabexate; Guanidines; Humans; In Vitro Techniques; Protease Inhibitors; Rats; Rats, Inbred Strains; Thrombin; Thrombosis | 1983 |
Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats.
Topics: Animals; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Guanidines; Kidney Glomerulus; Platelet Count; Rats; Rats, Inbred Strains; Shock, Septic | 1983 |
The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.
Topics: Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Humans; Male; Middle Aged; Recombinant Proteins; Solubility; Survival Rate; Thrombomodulin; Treatment Outcome | 2016 |
Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Topics: Adolescent; Aged; Aged, 80 and over; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gabexate; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prothrombin Time; Recombinant Proteins; Retrospective Studies; Thrombomodulin; Treatment Outcome; Young Adult | 2018 |